Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DFTX compared with SNYR: revenue, margins and what each company keeps, and the suppliers and customers both name
DFTX
Definium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
SNYR
Synergy CHC Corp.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DFTX
Definium Therapeutics, Inc.
vs
SNYR
Synergy CHC Corp.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DFTX, solid
SNYR, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: DFTX, SNYR.
Role chip = supplier or customer
Source: SEC EDGAR
Revenue flow
DFTX: latest quarter not drawable. SNYR: latest quarter is a loss; flow not drawable.
Method
›
DFTX
Definium Therapeutics, Inc.
Change
32.70
· pre 32.38
· delayed
Mkt cap
$4.4B
Revenue
—
Revenue
—
SNYR
Synergy CHC Corp.
Change
Pre-market
Nov 4 '26
delayed
Mkt cap
—
Revenue
$5M
Q1 FY26
Revenue
$30M
FY25
vs
Compare
Pre-market
Nov 4 '26
delayed
DFTX
Definium Therapeutics, Inc.
vs
SNYR
Synergy CHC Corp.
32.70
pre 32.38
delayed
Price
$4.4B
Mkt cap
—
—
Revenue
$5M
Q1 FY26
—
Revenue
$30M
FY25
Change
Change
DFTX
32.70
vs
SNYR
Pre-market
Nov 4 '26
delayed